BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 12669136)

  • 1. Inappropriate use of positive predictive value in describing the rapid collagen binding assay for von Willebrand factor cleaving protease.
    Knovich MA; Case D; Owen J
    Thromb Haemost; 2003 Apr; 89(4):768-9. PubMed ID: 12669136
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical use of a rapid collagen binding assay for von Willebrand factor cleaving protease in patients with thrombotic thrombocytopenic purpura.
    Rick ME; Moll S; Taylor MA; Krizek DM; White GC; Aronson DL
    Thromb Haemost; 2002 Oct; 88(4):598-604. PubMed ID: 12362230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
    Furlan M; Robles R; Galbusera M; Remuzzi G; Kyrle PA; Brenner B; Krause M; Scharrer I; Aumann V; Mittler U; Solenthaler M; Lämmle B
    N Engl J Med; 1998 Nov; 339(22):1578-84. PubMed ID: 9828245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
    Sarkodee-Adoo C; Gojo I; Heyman MR
    N Engl J Med; 1999 Apr; 340(17):1368; author reply 1369. PubMed ID: 10223876
    [No Abstract]   [Full Text] [Related]  

  • 5. Assay of von Willebrand factor (vWF)-cleaving protease based on decreased collagen binding affinity of degraded vWF: a tool for the diagnosis of thrombotic thrombocytopenic purpura (TTP).
    Gerritsen HE; Turecek PL; Schwarz HP; Lämmle B; Furlan M
    Thromb Haemost; 1999 Nov; 82(5):1386-9. PubMed ID: 10595623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deficient activity of von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura.
    Furlan M
    Expert Rev Cardiovasc Ther; 2003 Jul; 1(2):243-55. PubMed ID: 15030284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The "cutting" edge: von Willebrand factor-cleaving protease activity in thrombotic microangiopathies.
    Haspel RL; Jarolím P
    Transfus Apher Sci; 2005 Apr; 32(2):177-84. PubMed ID: 15784452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hemolytic uremic syndrome and thrombotic thrombocytopenic purpura].
    Masset C; Dubois B; Rorive G
    Rev Med Liege; 2002 Jan; 57(1):33-9. PubMed ID: 11899496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease.
    Furlan M; Lämmle B
    Best Pract Res Clin Haematol; 2001 Jun; 14(2):437-54. PubMed ID: 11686108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [vWF-cleaving protease/ADAMTS 13].
    Matsumoto M; Yagi H; Fujimura Y
    Rinsho Ketsueki; 2003 Mar; 44(3):159-67. PubMed ID: 12722342
    [No Abstract]   [Full Text] [Related]  

  • 11. Thrombotic microangiopathies.
    Nzerue CM
    N Engl J Med; 2002 Dec; 347(26):2171-3; author reply 2171-3. PubMed ID: 12501234
    [No Abstract]   [Full Text] [Related]  

  • 12. [Progress on TTP/HUS diagnosis with analysis of VWF-cleaving protease activation].
    Fujimura Y
    Nihon Naika Gakkai Zasshi; 2004 Mar; 93(3):451-9. PubMed ID: 15052802
    [No Abstract]   [Full Text] [Related]  

  • 13. Assays of von Willebrand factor-cleaving protease: a test for diagnosis of familial and acquired thrombotic thrombocytopenic purpura.
    Furlan M; Lämmle B
    Semin Thromb Hemost; 2002 Apr; 28(2):167-72. PubMed ID: 11992240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Not known from ADAM(TS-13)--novel insights into the pathophysiology of thrombotic microangiopathies.
    Wolf G
    Nephrol Dial Transplant; 2004 Jul; 19(7):1687-93. PubMed ID: 15128885
    [No Abstract]   [Full Text] [Related]  

  • 15. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.
    Warwicker P; Goodship JA; Goodship TH
    N Engl J Med; 1999 Apr; 340(17):1368-9. PubMed ID: 10223877
    [No Abstract]   [Full Text] [Related]  

  • 16. Thrombotic microangiopathy in malignant hypertension and hemolytic uremic syndrome (HUS)/ thrombotic thrombocytopenic purpura (TTP): can we differentiate one from the other?
    Shibagaki Y; Fujita T
    Hypertens Res; 2005 Jan; 28(1):89-95. PubMed ID: 15969259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombotic thrombocytopenic purpura: a simpler diagnosis at last?
    Mannucci PM
    Thromb Haemost; 1999 Nov; 82(5):1380-1. PubMed ID: 10595621
    [No Abstract]   [Full Text] [Related]  

  • 18. Molecular mechanisms in thrombotic thrombocytopenic purpura.
    Tsai HM
    Semin Thromb Hemost; 2004 Oct; 30(5):549-57. PubMed ID: 15497097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura.
    Tsai HM; Lian EC
    N Engl J Med; 1998 Nov; 339(22):1585-94. PubMed ID: 9828246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in thrombotic thrombocytopenic purpura.
    Sadler JE; Moake JL; Miyata T; George JN
    Hematology Am Soc Hematol Educ Program; 2004; ():407-23. PubMed ID: 15561695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.